Evidence map›Paper›PMID 41743087›Full record

ArticleFrontiers in medicine2026

Multispectral imaging and autofluorescence photobleaching combined in a multi-head neural network for skin cancer classification.

Vilen Jumutc, Andrey Bondarenko, Mihails Kovalovs, Ilze Lihacova, Alexey Lihachev, Dmitrijs Bļizņuks

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vilen JumutcInstitute of Applied Computer Systems, Riga Technical University, Riga, Latvia.
Andrey BondarenkoInstitute of Applied Computer Systems, Riga Technical University, Riga, Latvia.
Mihails KovalovsInstitute of Applied Computer Systems, Riga Technical University, Riga, Latvia.
Ilze LihacovaInstitute of Atomic Physics and Spectroscopy, University of Latvia, Riga, Latvia.
Alexey LihachevInstitute of Atomic Physics and Spectroscopy, University of Latvia, Riga, Latvia.
Dmitrijs BļizņuksInstitute of Applied Computer Systems, Riga Technical University, Riga, Latvia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The classification of hyperspectral images for skin cancer presents a significant challenge due to high data dimensionality and subtle differences between melanoma and non-melanoma tissues. This study investigates the efficacy of multi-target, multi-head neural network architectures for improving accuracy and precision-recall performance in hyperspectral melanoma classification. Methods: We use a proprietary multispectral dataset enriched with autofluorescence photobleaching tabular data, previously developed for skin lesion classification. Our method applies a multi-head architecture in which each head uses a different loss function, designed to optimize specific parts of the classification task. The network simultaneously learns from multiple data modalities, improving its ability to detect hidden features indicative of skin cancer. Final classifications are obtained by aggregating the outputs from all heads via simple averaging. Results: Results demonstrate significant improvements in classification accuracy and robustness compared to conventional single-head models. Our multi-head, multi-loss approach achieves the best performance on both evaluated data sources, with AUC-PR scores of 0.850 ± 0.032 and 0.822 ± 0.022 for the proprietary and ISIC datasets, respectively. Discussion: These findings indicate that multi-head architectures with specialized loss functions offer a powerful means of enhancing hyperspectral image classification, particularly for skin cancer detection, and provide a promising direction for future research and clinical applications.

Indexed as

deep learningmulti-head architectureneural networksphotobleachingskin cancer

Identifiers

PMID41743087
PMCPMC12929098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.